A landscape of pharmacogenomic interaction in cancer:
Resources and Results
This website and linked web pages contain data objects, results and supplementary data items related to and/or presented in the paper A landscape of pharmacogenomic interactions in cancer [Iorio et al, Cell 2016]. All the content is available in the table below and it also distributed across a set of web-pages (accessible through the below menu) roughly related to individual data-curation/analytical-aspects of the study.
The below table contains also tags indicating the data omic covered by the corresponding item or specifying if this is an annotation objects, as defined below:
SEQ: genomic variants, coded genomic variants, generally from whole exome sequencing (WES) profiles;
CNV: coded or plain information about copy number altered genes and chromosomal segments;
METH: coded or plain epigenomic data;
EXP: trascriptional data;
DR: raw or processed, drug response data and drug sensitivity indicators;
MULT: combination of different data types (for example, somatic mutations and copy number alterations for a sub set of samples);
ANN: annotation items (such as, sample name catalogues, studies, tissue classifications etc.);
The second column roughly indicates the amount of processing performed to generate the item in a given row. Tags in this column ranges from Raw (for raw data) to Analysis (for results of the study).
Copyright (c) 2014 - 2024, EMBL - European Bioinformatics Institute and Wellcome Trust Sanger Institute - Author: Francesco Iorio (iorio@ebi.ac.uk)
Distributed under the GPLv3 License.
See file LICENSE.txt at http://www.gnu.org/licenses/gpl-3.0.html